SMX-20537-61680 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-26
Dose 1 — Pfizer-BioNTech
2022-07-17
Dose 2 — Pfizer-BioNTech
2022-09-18
Dose 3 — Pfizer-BioNTech
2022-10-11
Registered in v-safe
2022-10-11
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in
2022-10-17
Health check-in — day 28, dose 3, dependent
Feeling: Good

Adult check-in
2022-10-25
Survey response — day 35, dose 3, dependent
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: Cold like sx

MedDRA releases: 2024-11 · check-in free text available
2022-10-30
Survey response — day 42, dose 3, dependent
MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair

Free text: Congestion and runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-12-18
Survey response — 3 months, dose 3, dependent
MedDRA: Influenza, Respiratory syncytial virus infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Rsv and flu

MedDRA releases: 2024-11 · check-in free text available
2022-12-18
Report sent to call center — 3 months, dose 3, dependent
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-19
Call 1 — Left Voicemail
2023-03-19
Health check-in — 6 months, dose 3, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-26	Pfizer-BioNTech	No
2	2022-07-17	Pfizer-BioNTech	No
3	2022-09-18	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-12-18	Unsuccessful

Free text

Release 12 — day 35, dose 3, dependent

2022-10-25

Symptoms: Cold like sx

Release 12 — day 42, dose 3, dependent

2022-10-30

Symptoms: Congestion and runny nose

Release 12 — 3 months, dose 3, dependent

2022-12-18

Symptoms: Rsv and flu

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release